Study of AK119 Combined With AK104 in Patients With Advanced Solid Tumors

Clinical trial NCT05559541 · TERMINATED

Trial details

NCT number: NCT05559541
Sponsor: Akeso
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor, Adult

Start date: 2022-12-15
Primary completion: 2024-05-31
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.